BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32075941)

  • 1. Filamin A inhibition reduces seizure activity in a mouse model of focal cortical malformations.
    Zhang L; Huang T; Teaw S; Nguyen LH; Hsieh LS; Gong X; Burns LH; Bordey A
    Sci Transl Med; 2020 Feb; 12(531):. PubMed ID: 32075941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A brain somatic RHEB doublet mutation causes focal cortical dysplasia type II.
    Zhao S; Li Z; Zhang M; Zhang L; Zheng H; Ning J; Wang Y; Wang F; Zhang X; Gan H; Wang Y; Zhang X; Luo H; Bu G; Xu H; Yao Y; Zhang YW
    Exp Mol Med; 2019 Jul; 51(7):1-11. PubMed ID: 31337748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
    Nguyen LH; Mahadeo T; Bordey A
    J Neurosci; 2019 Apr; 39(14):2762-2773. PubMed ID: 30700531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic HCN4 expression drives mTOR-dependent epilepsy in mice.
    Hsieh LS; Wen JH; Nguyen LH; Zhang L; Getz SA; Torres-Reveron J; Wang Y; Spencer DD; Bordey A
    Sci Transl Med; 2020 Nov; 12(570):. PubMed ID: 33208499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of somatic and germline pathogenic variants in adult cohort of drug-resistant focal epilepsies.
    Ferri L; Menghi V; Licchetta L; Dimartino P; Minardi R; Davì C; Di Vito L; Cifaldi E; Zenesini C; Gozzo F; Pelliccia V; Mariani V; de Spelorzi YCC; Gustincich S; Seri M; Tassi L; Pippucci T; Bisulli F
    Epilepsy Behav; 2024 Apr; 153():109716. PubMed ID: 38508103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic variants in new candidate genes identified in focal cortical dysplasia type II.
    Zhang Z; Gao K; Liu Q; Zhou J; Li X; Lang N; Liu M; Wang T; Zhang J; Wang H; Dong Y; Ji T; Wang S; Liu X; Jiang Y; Cai L; Wu Y
    Epilepsia; 2020 Apr; 61(4):667-678. PubMed ID: 32216069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.
    Lim JS; Kim WI; Kang HC; Kim SH; Park AH; Park EK; Cho YW; Kim S; Kim HM; Kim JA; Kim J; Rhee H; Kang SG; Kim HD; Kim D; Kim DS; Lee JH
    Nat Med; 2015 Apr; 21(4):395-400. PubMed ID: 25799227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.
    Lim JS; Gopalappa R; Kim SH; Ramakrishna S; Lee M; Kim WI; Kim J; Park SM; Lee J; Oh JH; Kim HD; Park CH; Lee JS; Kim S; Kim DS; Han JM; Kang HC; Kim HH; Lee JH
    Am J Hum Genet; 2017 Mar; 100(3):454-472. PubMed ID: 28215400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epilepsy in the mTORopathies: opportunities for precision medicine.
    Moloney PB; Cavalleri GL; Delanty N
    Brain Commun; 2021; 3(4):fcab222. PubMed ID: 34632383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting pathological cells with senolytic drugs reduces seizures in neurodevelopmental mTOR-related epilepsy.
    Ribierre T; Bacq A; Donneger F; Doladilhe M; Maletic M; Roussel D; Le Roux I; Chassoux F; Devaux B; Adle-Biassette H; Ferrand-Sorbets S; Dorfmüller G; Chipaux M; Baldassari S; Poncer JC; Baulac S
    Nat Neurosci; 2024 Jun; 27(6):1125-1136. PubMed ID: 38710875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia.
    Ljungberg MC; Sunnen CN; Lugo JN; Anderson AE; D'Arcangelo G
    Dis Model Mech; 2009; 2(7-8):389-98. PubMed ID: 19470613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-seizure gene therapy for focal cortical dysplasia.
    Almacellas Barbanoj A; Graham RT; Maffei B; Carpenter JC; Leite M; Hoke J; Hardjo F; Scott-Solache J; Chimonides C; Schorge S; Kullmann DM; Magloire V; Lignani G
    Brain; 2024 Feb; 147(2):542-553. PubMed ID: 38100333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTOR-therapy and targeted treatment opportunities in mTOR-related epilepsies associated with cortical malformations.
    Auvin S; Baulac S
    Rev Neurol (Paris); 2023 Apr; 179(4):337-344. PubMed ID: 36906459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.
    Scholl T; Mühlebner A; Ricken G; Gruber V; Fabing A; Samueli S; Gröppel G; Dorfer C; Czech T; Hainfellner JA; Prabowo AS; Reinten RJ; Hoogendijk L; Anink JJ; Aronica E; Feucht M
    Brain Pathol; 2017 Nov; 27(6):770-780. PubMed ID: 27750396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome c oxidase deficit is associated with the seizure onset zone in young patients with focal cortical dysplasia Type II.
    Miles L; Greiner HM; Mangano FT; Horn PS; Leach JL; Miles MV
    Metab Brain Dis; 2015 Oct; 30(5):1151-60. PubMed ID: 25957585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypervascularization in mTOR-dependent focal and global cortical malformations displays differential rapamycin sensitivity.
    Zhang L; Huang T; Teaw S; Bordey A
    Epilepsia; 2019 Jun; 60(6):1255-1265. PubMed ID: 31125447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
    Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MEK-ERK signaling reduces seizures in two mouse models of tuberous sclerosis complex.
    Nguyen LH; Leiser SC; Song D; Brunner D; Roberds SL; Wong M; Bordey A
    Epilepsy Res; 2022 Mar; 181():106890. PubMed ID: 35219048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal malformations of cortical development: new vistas for molecular pathogenesis.
    Lim KC; Crino PB
    Neuroscience; 2013 Nov; 252():262-76. PubMed ID: 23892008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis.
    Yasin SA; Ali AM; Tata M; Picker SR; Anderson GW; Latimer-Bowman E; Nicholson SL; Harkness W; Cross JH; Paine SM; Jacques TS
    Acta Neuropathol; 2013 Aug; 126(2):207-18. PubMed ID: 23728790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.